VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q51792245 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241120235807.0
008 241120nneanz||abbn n and d
035 ‎‡a (WKP)Q51792245‏
024 ‎‡a 0000-0002-2473-7029‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q51792245‏
100 0 ‎‡a James M Fox‏ ‎‡9 ast‏ ‎‡9 de‏ ‎‡9 hu‏ ‎‡9 sl‏ ‎‡9 es‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a জেমস এম ফক্স‏ ‎‡9 bn‏
400 0 ‎‡a James M Fox‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a James M Fox‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's Beta-Adrenoceptor Activation Reduces Both Dermal Microvascular Endothelial Cell Migration via a cAMP-Dependent Mechanism and Wound Angiogenesis‏
670 ‎‡a Author's CCR5 susceptibility to ligand-mediated down-modulation differs between human T lymphocytes and myeloid cells.‏
670 ‎‡a Author's Circularised 1 and 2 LTR DNA circles are present in freshly- and chronically-infected cell lines and patient PBMCs, indicating ongoing reverse transcriptase usage‏
670 ‎‡a Author's Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.‏
670 ‎‡a Author's Corrigendum to "Methodology for reliable and reproducible cryopreservation of human cervical tissue" [Cryobiology 77‏
670 ‎‡a Author's Corrigendum to "Methodology for reliable and reproducible cryopreservation of human cervical tissue" [Cryobiology 77 (August) (2017) 14-18].‏
670 ‎‡a Author's CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3.‏
670 ‎‡a Author's CXCL4/Platelet Factor 4 is an agonist of CCR1 and drives human monocyte migration.‏
670 ‎‡a Author's Epidermal growth factor can signal via β-catenin to control proliferation of mesenchymal stem cells independently of canonical Wnt signalling‏
670 ‎‡a Author's Flow cytometric methodology for the detection of de novo human T-cell leukemia virus -1 infection in vitro: A tool to study novel infection inhibitors‏
670 ‎‡a Author's Glycans modify mesenchymal stem cell differentiation to impact the function of resulting osteoblasts‏
670 ‎‡a Author's Hepatitis B vaccination induces mucosal antibody responses in the female genital tract, indicating potential mechanisms of protection against infection‏
670 ‎‡a Author's Long Terminal Repeat Circular DNA as Markers of Active Viral Replication of Human T Lymphotropic Virus-1 in Vivo‏
670 ‎‡a Author's Mechanisms regulating chemokine receptor activity‏
670 ‎‡a Author's Methodology for reliable and reproducible cryopreservation of human cervical tissue.‏
670 ‎‡a Author's Methodology to reduce formaldehyde exposure during laboratory fumigation.‏
670 ‎‡a Author's Multiparameter Analysis of Human Bone Marrow Stromal Cells Identifies Distinct Immunomodulatory and Differentiation-Competent Subtypes.‏
670 ‎‡a Author's Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validation‏
670 ‎‡a Author's Prevalence of hepatitis C virus in mothers and their children in Malawi‏
670 ‎‡a Author's Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients‏
670 ‎‡a Author's Sero-prevalence of HTLV 1/2 and HCV in paired mother and children from Malawi as well as systematic review and meta-analysis of HTLV-1/2 and HCV of data available on women and children living in Africa.‏
670 ‎‡a Author's Seroprevalence of HTLV-1 and HTLV-2 amongst mothers and children in Malawi within the context of a systematic review and meta-analysis of HTLV seroprevalence in Africa‏
670 ‎‡a Author's Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist.‏
670 ‎‡a Author's Yaba-like disease virus chemokine receptor 7L, a CCR8 orthologue.‏
670 ‎‡a Author's Yaba-like disease virus protein 7L is a cell-surface receptor for chemokine CCL1.‏
909 ‎‡a (orcid) 0000000224737029‏ ‎‡9 1‏
919 ‎‡a betaadrenoceptoractivationreducesbothdermalmicrovascularendothelialcellmigrationviaacampdependentmechanismandwoundangiogenesis‏ ‎‡A Beta-Adrenoceptor Activation Reduces Both Dermal Microvascular Endothelial Cell Migration via a cAMP-Dependent Mechanism and Wound Angiogenesis‏ ‎‡9 1‏
919 ‎‡a ccr5susceptibilitytoligandmediateddownmodulationdiffersbetweenhumantlymphocytesandmyeloidcells‏ ‎‡A CCR5 susceptibility to ligand-mediated down-modulation differs between human T lymphocytes and myeloid cells.‏ ‎‡9 1‏
919 ‎‡a circularised1and2ltrdnacirclesarepresentinfreshlyandchronicallyinfectedcelllinesandpatientpbmcsindicatingongoingreversetranscriptaseusage‏ ‎‡A Circularised 1 and 2 LTR DNA circles are present in freshly- and chronically-infected cell lines and patient PBMCs, indicating ongoing reverse transcriptase usage‏ ‎‡9 1‏
919 ‎‡a concisereviewmesenchymalstemcellstheirphenotypedifferentiationcapacityimmunologicalfeaturesandpotentialforhoming‏ ‎‡A Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.‏ ‎‡9 1‏
919 ‎‡a corrigendumtomethodologyforreliableandreproduciblecryopreservationofhumancervicaltissuecryobiology77‏ ‎‡A Corrigendum to "Methodology for reliable and reproducible cryopreservation of human cervical tissue" [Cryobiology 77‏ ‎‡9 1‏
919 ‎‡a corrigendumtomethodologyforreliableandreproduciblecryopreservationofhumancervicaltissue‏ ‎‡A Corrigendum to "Methodology for reliable and reproducible cryopreservation of human cervical tissue" [Cryobiology 77 (August) (2017) 14-18].‏ ‎‡9 1‏
919 ‎‡a cxcl4inducedmigrationofactivatedtlymphocytesismediatedbythechemokinereceptorcxcr3‏ ‎‡A CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3.‏ ‎‡9 1‏
919 ‎‡a cxcl4plateletfactor4isanagonistofccr1anddriveshumanmonocytemigration‏ ‎‡A CXCL4/Platelet Factor 4 is an agonist of CCR1 and drives human monocyte migration.‏ ‎‡9 1‏
919 ‎‡a epidermalgrowthfactorcansignalviaβcatenintocontrolproliferationofmesenchymalstemcellsindependentlyofcanonicalwntsignalling‏ ‎‡A Epidermal growth factor can signal via β-catenin to control proliferation of mesenchymal stem cells independently of canonical Wnt signalling‏ ‎‡9 1‏
919 ‎‡a flowcytometricmethodologyforthedetectionofdenovohumantcellleukemiavirus1infectioninvitroatooltostudynovelinfectioninhibitors‏ ‎‡A Flow cytometric methodology for the detection of de novo human T-cell leukemia virus -1 infection in vitro: A tool to study novel infection inhibitors‏ ‎‡9 1‏
919 ‎‡a glycansmodifymesenchymalstemcelldifferentiationtoimpactthefunctionofresultingosteoblasts‏ ‎‡A Glycans modify mesenchymal stem cell differentiation to impact the function of resulting osteoblasts‏ ‎‡9 1‏
919 ‎‡a hepatitisbvaccinationinducesmucosalantibodyresponsesinthefemalegenitaltractindicatingpotentialmechanismsofprotectionagainstinfection‏ ‎‡A Hepatitis B vaccination induces mucosal antibody responses in the female genital tract, indicating potential mechanisms of protection against infection‏ ‎‡9 1‏
919 ‎‡a longterminalrepeatcirculardnaasmarkersofactiveviralreplicationofhumantlymphotropicvirus1invivo‏ ‎‡A Long Terminal Repeat Circular DNA as Markers of Active Viral Replication of Human T Lymphotropic Virus-1 in Vivo‏ ‎‡9 1‏
919 ‎‡a mechanismsregulatingchemokinereceptoractivity‏ ‎‡A Mechanisms regulating chemokine receptor activity‏ ‎‡9 1‏
919 ‎‡a methodologyforreliableandreproduciblecryopreservationofhumancervicaltissue‏ ‎‡A Methodology for reliable and reproducible cryopreservation of human cervical tissue.‏ ‎‡9 1‏
919 ‎‡a methodologytoreduceformaldehydeexposureduringlaboratoryfumigation‏ ‎‡A Methodology to reduce formaldehyde exposure during laboratory fumigation.‏ ‎‡9 1‏
919 ‎‡a multiparameteranalysisofhumanbonemarrowstromalcellsidentifiesdistinctimmunomodulatoryanddifferentiationcompetentsubtypes‏ ‎‡A Multiparameter Analysis of Human Bone Marrow Stromal Cells Identifies Distinct Immunomodulatory and Differentiation-Competent Subtypes.‏ ‎‡9 1‏
919 ‎‡a predictionsofccr1chemokinereceptorstructureandbx471antagonistbindingfollowedbyexperimentalvalidation‏ ‎‡A Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validation‏ ‎‡9 1‏
919 ‎‡a prevalenceofhepatitis100virusinmothersandtheirchildreninmalawi‏ ‎‡A Prevalence of hepatitis C virus in mothers and their children in Malawi‏ ‎‡9 1‏
919 ‎‡a rapiddisseminationofhumantlymphotropicvirustype1duringprimaryinfectionintransplantrecipients‏ ‎‡A Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients‏ ‎‡9 1‏
919 ‎‡a seroprevalenceofhtlv12andhcvinpairedmotherandchildrenfrommalawiaswellassystematicreviewandmetaanalysisofhtlv12andhcvofdataavailableonwomenandchildrenlivinginafrica‏ ‎‡A Sero-prevalence of HTLV 1/2 and HCV in paired mother and children from Malawi as well as systematic review and meta-analysis of HTLV-1/2 and HCV of data available on women and children living in Africa.‏ ‎‡9 1‏
919 ‎‡a seroprevalenceofhtlv1andhtlv2amongstmothersandchildreninmalawiwithinthecontextofasystematicreviewandmetaanalysisofhtlvseroprevalenceinafrica‏ ‎‡A Seroprevalence of HTLV-1 and HTLV-2 amongst mothers and children in Malawi within the context of a systematic review and meta-analysis of HTLV seroprevalence in Africa‏ ‎‡9 1‏
919 ‎‡a structurefunctionrelationshipsofccr8agonistsandantagonistsaminoterminalextensionofccl1byasingleaminoacidgeneratesapartialagonist‏ ‎‡A Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist.‏ ‎‡9 1‏
919 ‎‡a yabalikediseaseviruschemokinereceptor7laccr8orthologue‏ ‎‡A Yaba-like disease virus chemokine receptor 7L, a CCR8 orthologue.‏ ‎‡9 1‏
919 ‎‡a yabalikediseasevirusprotein7lisacellsurfacereceptorforchemokineccl1‏ ‎‡A Yaba-like disease virus protein 7L is a cell-surface receptor for chemokine CCL1.‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 LC|n 2015028331‏
996 ‎‡2 NTA|241434750‏
996 ‎‡2 LC|n 50023154‏
996 ‎‡2 NUKAT|n 2003081859‏
996 ‎‡2 J9U|987007450043905171‏
996 ‎‡2 BLBNB|000322555‏
996 ‎‡2 LC|n 92005263‏
996 ‎‡2 N6I|vtls002072262‏
996 ‎‡2 N6I|vtls000116020‏
996 ‎‡2 SUDOC|035794291‏
996 ‎‡2 J9U|987007333426905171‏
996 ‎‡2 DNB|1037757327‏
996 ‎‡2 BNF|13489146‏
996 ‎‡2 BNC|981058521821106706‏
996 ‎‡2 LC|no2019008197‏
996 ‎‡2 LC|no2022142580‏
996 ‎‡2 LC|nb2007025411‏
996 ‎‡2 ISNI|0000000121372397‏
996 ‎‡2 ISNI|0000000107946622‏
996 ‎‡2 ISNI|0000000385632586‏
996 ‎‡2 NUKAT|n 2006127404‏
996 ‎‡2 LC|no2011039933‏
996 ‎‡2 SUDOC|204248701‏
996 ‎‡2 LC|n 2021036571‏
996 ‎‡2 BIBSYS|90234506‏
996 ‎‡2 LC|n 00102542‏
996 ‎‡2 LC|no2018052241‏
996 ‎‡2 BNF|10897946‏
996 ‎‡2 LC|no2024095412‏
996 ‎‡2 SUDOC|140770097‏
996 ‎‡2 LC|no2006080824‏
996 ‎‡2 NKC|kup19990000028559‏
996 ‎‡2 ISNI|0000000030774585‏
996 ‎‡2 NUKAT|n 2016176056‏
996 ‎‡2 CAOONL|ncf11287556‏
996 ‎‡2 BNF|14098647‏
996 ‎‡2 RERO|A003256553‏
996 ‎‡2 LC|nr 00024433‏
996 ‎‡2 BNF|12066995‏
996 ‎‡2 LC|n 80041230‏
996 ‎‡2 PLWABN|9813695350105606‏
996 ‎‡2 BIBSYS|1634281495019‏
996 ‎‡2 NTA|184799309‏
996 ‎‡2 RERO|A018122301‏
996 ‎‡2 BNF|13490380‏
996 ‎‡2 LC|n 2019052512‏
996 ‎‡2 LC|n 2023004332‏
996 ‎‡2 ISNI|0000000454693084‏
996 ‎‡2 LC|no2020096449‏
996 ‎‡2 ISNI|0000000030561715‏
996 ‎‡2 BNE|XX6008233‏
996 ‎‡2 LC|n 2022058260‏
996 ‎‡2 NUKAT|n 2019203147‏
996 ‎‡2 ISNI|0000000394683190‏
996 ‎‡2 SUDOC|277048168‏
996 ‎‡2 SUDOC|051837757‏
996 ‎‡2 LC|n 2015004074‏
996 ‎‡2 BNC|981058617120906706‏
996 ‎‡2 ISNI|0000000119449439‏
996 ‎‡2 CAOONL|ncf12140123‏
996 ‎‡2 N6I|vtls000108307‏
996 ‎‡2 BIBSYS|90182716‏
996 ‎‡2 SZ|1225488699‏
996 ‎‡2 W2Z|1070483‏
996 ‎‡2 J9U|987007429565405171‏
996 ‎‡2 ISNI|0000000031368562‏
996 ‎‡2 ISNI|0000000114918988‏
996 ‎‡2 ISNI|000000038746132X‏
996 ‎‡2 ISNI|0000000023086290‏
996 ‎‡2 ISNI|0000000048128952‏
996 ‎‡2 BNF|14066014‏
996 ‎‡2 BLBNB|000208661‏
996 ‎‡2 LC|n 81044008‏
996 ‎‡2 LC|no2003016902‏
996 ‎‡2 LC|n 81011326‏
996 ‎‡2 ISNI|0000000110599828‏
996 ‎‡2 BNF|13795568‏
996 ‎‡2 ISNI|0000000403409186‏
996 ‎‡2 DNB|17114676X‏
996 ‎‡2 NSK|000650645‏
996 ‎‡2 ISNI|0000000379144762‏
996 ‎‡2 J9U|987007432990105171‏
996 ‎‡2 ISNI|0000000108438996‏
996 ‎‡2 PTBNP|256349‏
996 ‎‡2 BIBSYS|15038750‏
996 ‎‡2 DNB|1161564454‏
996 ‎‡2 LNB|LNC10-000347354‏
996 ‎‡2 LC|n 85236964‏
996 ‎‡2 LC|no2012094947‏
996 ‎‡2 LC|n 88073236‏
996 ‎‡2 DNB|171647599‏
996 ‎‡2 SUDOC|139626719‏
996 ‎‡2 BNF|11976055‏
996 ‎‡2 SUDOC|029184800‏
996 ‎‡2 RERO|A018142209‏
996 ‎‡2 LC|no 91015231‏
996 ‎‡2 BNF|13894093‏
996 ‎‡2 LC|no2022094930‏
996 ‎‡2 LC|no 95000361‏
996 ‎‡2 LC|no2022081745‏
996 ‎‡2 ISNI|0000000020371192‏
996 ‎‡2 W2Z|1656996719865‏
996 ‎‡2 NTA|181986442‏
996 ‎‡2 LC|nb2014004055‏
996 ‎‡2 LC|n 87948700‏
996 ‎‡2 BIBSYS|90174577‏
996 ‎‡2 LIH|LNB:C_b__g_C;=B_f_‏
996 ‎‡2 ISNI|0000000114506596‏
996 ‎‡2 NII|DA15932894‏
996 ‎‡2 NDL|00754720‏
996 ‎‡2 LC|n 87142583‏
996 ‎‡2 DBC|87097968318653‏
996 ‎‡2 NTA|06940416X‏
996 ‎‡2 J9U|987007360083205171‏
996 ‎‡2 SUDOC|094358060‏
996 ‎‡2 NTA|071767959‏
996 ‎‡2 LNB|LNC10-000189653‏
996 ‎‡2 NSK|000573347‏
996 ‎‡2 BIBSYS|90898736‏
996 ‎‡2 DNB|13970776X‏
996 ‎‡2 DNB|1053248628‏
996 ‎‡2 J9U|987007436522805171‏
996 ‎‡2 JPG|500080292‏
996 ‎‡2 LC|no2019153146‏
996 ‎‡2 BNF|17004697‏
996 ‎‡2 LC|n 98108035‏
996 ‎‡2 ISNI|0000000109762966‏
996 ‎‡2 BIBSYS|1070483‏
996 ‎‡2 SUDOC|060982659‏
996 ‎‡2 LC|n 93119027‏
996 ‎‡2 LC|n 50058313‏
996 ‎‡2 LC|n 2021056960‏
996 ‎‡2 J9U|987007369378705171‏
996 ‎‡2 ISNI|0000000001250053‏
996 ‎‡2 NTA|071048189‏
996 ‎‡2 LC|n 80063519‏
996 ‎‡2 LC|n 83066720‏
996 ‎‡2 CAOONL|ncf10019737‏
996 ‎‡2 J9U|987007416165905171‏
996 ‎‡2 LC|no2010204472‏
996 ‎‡2 NSK|000037230‏
996 ‎‡2 J9U|987007407325805171‏
996 ‎‡2 NII|DA04602854‏
996 ‎‡2 ISNI|0000000108552078‏
996 ‎‡2 LC|n 2024020956‏
996 ‎‡2 NLA|000035777359‏
996 ‎‡2 SKMASNL|vtls001785834‏
996 ‎‡2 ISNI|0000000022616763‏
996 ‎‡2 NTA|252131444‏
996 ‎‡2 BNF|12549959‏
996 ‎‡2 LC|n 82160265‏
996 ‎‡2 NTA|397140452‏
996 ‎‡2 LIH|LNB:CZ0_d_;=BX‏
996 ‎‡2 NII|DA00253720‏
996 ‎‡2 LC|no2004048897‏
996 ‎‡2 BIBSYS|90152820‏
996 ‎‡2 ISNI|0000000036539623‏
996 ‎‡2 LC|no2024117445‏
996 ‎‡2 NKC|xx0188390‏
996 ‎‡2 NTA|074826247‏
996 ‎‡2 DNB|1274883865‏
996 ‎‡2 ISNI|0000000389915006‏
996 ‎‡2 NTA|069229554‏
996 ‎‡2 J9U|987007338127305171‏
996 ‎‡2 LC|n 82005469‏
996 ‎‡2 ISNI|0000000118470033‏
996 ‎‡2 LC|no2003039487‏
996 ‎‡2 DNB|1075605369‏
996 ‎‡2 NSK|000476559‏
996 ‎‡2 ISNI|0000000030381351‏
996 ‎‡2 KRNLK|KAC200903287‏
996 ‎‡2 LC|n 84134866‏
996 ‎‡2 LC|n 80059668‏
996 ‎‡2 DNB|140971661‏
996 ‎‡2 NLA|000035720971‏
996 ‎‡2 LC|n 85303721‏
996 ‎‡2 PTBNP|269525‏
996 ‎‡2 LIH|LNB:CXJ0;=BB‏
996 ‎‡2 LC|n 88028131‏
996 ‎‡2 CAOONL|ncf10095631‏
996 ‎‡2 NTA|069496498‏
996 ‎‡2 CAOONL|ncf11290642‏
996 ‎‡2 RERO|A024850976‏
996 ‎‡2 NII|DA07284926‏
996 ‎‡2 ISNI|0000000105738969‏
996 ‎‡2 NUKAT|n 2009080617‏
996 ‎‡2 NUKAT|n 2004048598‏
996 ‎‡2 SUDOC|088001954‏
996 ‎‡2 DNB|172078865‏
996 ‎‡2 NTA|110960742‏
996 ‎‡2 CAOONL|ncf12093391‏
996 ‎‡2 LC|nr2001031190‏
996 ‎‡2 LC|no2023029929‏
996 ‎‡2 LC|n 2014051384‏
996 ‎‡2 SUDOC|028937635‏
996 ‎‡2 LC|nr 95039488‏
996 ‎‡2 NKC|pna2005261879‏
996 ‎‡2 NUKAT|n 2009165261‏
996 ‎‡2 J9U|987012095560005171‏
996 ‎‡2 LC|n 79078711‏
996 ‎‡2 BNC|981058516185306706‏
996 ‎‡2 CAOONL|ncf10424032‏
996 ‎‡2 BNF|12086436‏
996 ‎‡2 BIBSYS|90067773‏
996 ‎‡2 VLACC|000031737‏
996 ‎‡2 NTA|073981214‏
996 ‎‡2 LC|no2013121342‏
996 ‎‡2 ISNI|0000000028541723‏
996 ‎‡2 ISNI|0000000047939876‏
996 ‎‡2 BIBSYS|90616074‏
996 ‎‡2 NDL|00513275‏
996 ‎‡2 DNB|1225488699‏
996 ‎‡2 PLWABN|9812829927405606‏
996 ‎‡2 LC|n 77019335‏
996 ‎‡2 ISNI|0000000436812166‏
996 ‎‡2 LC|n 2010061772‏
996 ‎‡2 J9U|987010982264305171‏
996 ‎‡2 LC|nr 91000719‏
996 ‎‡2 ISNI|0000000043455305‏
996 ‎‡2 ISNI|0000000063981572‏
996 ‎‡2 RERO|A014065599‏
996 ‎‡2 J9U|987007330909505171‏
996 ‎‡2 ISNI|000000003535829X‏
996 ‎‡2 LC|n 2007160351‏
996 ‎‡2 NII|DA00802192‏
996 ‎‡2 RERO|A003256550‏
996 ‎‡2 PLWABN|9810679598505606‏
996 ‎‡2 CAOONL|ncf12103386‏
996 ‎‡2 RERO|A003256554‏
996 ‎‡2 BIBSYS|1656996719865‏
996 ‎‡2 ISNI|0000000110275292‏
996 ‎‡2 LC|n 2022006277‏
996 ‎‡2 LIH|LNB:DP_v_C;=B_j_‏
996 ‎‡2 ISNI|0000000445316631‏
996 ‎‡2 RERO|A014065579‏
996 ‎‡2 NTA|070347522‏
996 ‎‡2 LC|no2010206076‏
996 ‎‡2 LC|no2017028924‏
996 ‎‡2 JPG|500351729‏
996 ‎‡2 DNB|171696719‏
996 ‎‡2 NII|DA02606275‏
996 ‎‡2 BNF|12535207‏
996 ‎‡2 NTA|069380627‏
996 ‎‡2 ISNI|0000000116159065‏
996 ‎‡2 VLACC|000044872‏
996 ‎‡2 ISNI|0000000073895184‏
996 ‎‡2 NDL|00730441‏
996 ‎‡2 SUDOC|199259208‏
996 ‎‡2 CAOONL|ncf11719487‏
996 ‎‡2 CAOONL|ncf11296183‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏
998 ‎‡a Fox, James M‏ ‎‡2 ISNI|0000000073895184‏ ‎‡3 exact name‏
998 ‎‡a James M. Fox‏ ‎‡2 ISNI|0000000073895184‏ ‎‡3 exact name‏
998 ‎‡a Fox, James M.‏ ‎‡2 ISNI|0000000073895184‏ ‎‡3 exact name‏